Cargando…

Rapid effect of suvorexant and high-dose melatonin on COVID-19 associated delirium

Detalles Bibliográficos
Autores principales:	Nazeer, Sahana, Preud'homme, Xavier, Rivelli, Sarah, Hankey, Maria Stack, Kablinger, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851718/ https://www.ncbi.nlm.nih.gov/pubmed/36801081 http://dx.doi.org/10.1016/j.genhosppsych.2023.01.006

Ejemplares similares

(82) Effect of Suvorexant on COVID-19 Associated Delirium
por: Nazeer, Sahana, et al.
Publicado: (2022)

Suvorexant for the prevention of delirium: A meta-analysis
por: Xu, Shu, et al.
Publicado: (2020)

Refined Method of Lipofilling following DIEP Breast Reconstruction: 3D Analysis of Graft Survival
por: Nelissen, Xavier, et al.
Publicado: (2015)

PT653. Experience using suvorexant to treat delirium
por: Fujiwara, Kodo, et al.
Publicado: (2016)

Delirium, sleep, COVID-19 and melatonin
por: Wiwanitkit, Viroj
Publicado: (2020)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

The mean age of gender dysphoria diagnosis is decreasing
por: Sun, Ching-Fang, et al.
Publicado: (2023)

Proceedings: B and T cell membrane markers in human leukaemias and lymphomata.
por: Seligmann, M., et al.
Publicado: (1975)

Management of Post-Liver-Transplant Delirium with Melatonin: A Case Report
por: Grover, Sandeep, et al.
Publicado: (2020)

Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting
por: Tamura, Kiyoshi, et al.
Publicado: (2018)

Collision Cross Section Prediction with Molecular Fingerprint Using Machine Learning
por: Yang, Fan, et al.
Publicado: (2022)

Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial
por: Azuma, Kazunari, et al.
Publicado: (2018)

Effect of Suvorexant on Nocturnal Delirium in Elderly Patients with Alzheimer’s Disease: A Case-series Study
por: Hanazawa, Tomoki, et al.
Publicado: (2019)

Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study
por: Ikeuchi, Shoya, et al.
Publicado: (2023)

Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015)

Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti, Joyce K, et al.
Publicado: (2016)

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018)

ZOLPIDEM INDUCED DELIRIUM
por: Sidana, Ajeet, et al.
Publicado: (2002)

Clinical recognition of delirium
por: Shaji, K. S., et al.
Publicado: (2014)

Reducing the effect of immortal time bias affects the analysis of prevention of delirium by suvorexant in critically ill patients: A retrospective cohort study
por: Shiotsuka, Junji, et al.
Publicado: (2022)

Melatonin supplementation for the prevention of hospital-associated delirium
por: Joseph, Sarah Gabrielle
Publicado: (2018)

Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)

Suvorexant for insomnia in older adults: a perspective review
por: Tampi, Rajesh R, et al.
Publicado: (2018)

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
por: Ito, Hiroshi, et al.
Publicado: (2021)

Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit
por: Azimaraghi, Omid, et al.
Publicado: (2020)

The Occurrence of Post-Operative Delirium in Brazil
por: da Silva Magalhães, Pedro Vieira, et al.
Publicado: (2008)

Fluoroquinolones: An under-recognized cause for delirium
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Dexmedetomidine and postoperative delirium: Decoding the evidence!
por: Magoon, Rohan, et al.
Publicado: (2020)

Delirium associated with discontinuation of sertraline in an elderly
por: Das, Subhash, et al.
Publicado: (2019)

Pharmacogenomics of sevoflurane: role in emergence delirium
por: Nair, Abhijit
Publicado: (2019)

Psychosis: glia, immunity, and melatonin
por: Anderson, George
Publicado: (2017)

Fluvoxamine, melatonin and COVID-19
por: Anderson, George M.
Publicado: (2021)

Melatonin’s actions are not limited to sleep
por: Venaki, Evangelia, et al.
Publicado: (2023)

Inertness of Superoxide Dismutase Mimics Mn(II) Complexes Based on an Open-Chain Ligand, Bioactivity, and Detection in Intestinal Epithelial Cells
por: Schanne, Gabrielle, et al.
Publicado: (2022)

Commentary to “Schizophrenia and COVID-19 Delirium”, an update
por: Palomar-Ciria, Nora, et al.
Publicado: (2020)

Adjuvant Trazodone for Management of Protracted Delirium Tremens
por: Kathiresan, Preethy, et al.
Publicado: (2020)

EEG and clinical assessment in delirium and acute encephalopathy
por: Hut, Suzanne C.A., et al.
Publicado: (2021)

Delirium awareness day: a portuguese perspective
por: Regueira, Patrícia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2opn9c82q3tisip34u0qlkssc